Skip navigation

Current Reports

Annual report 2011

Corporate overview & Annual report for the period ended June 30th 2011

Interim results 2011

Interims 2011.pdf (619.2 kB)

Annual report 2010

Corporate overview & Annual report for the period ended June 30th 2010

Download FY10 Annual report

IS Pharma Annual report 2010

Variquel (Haemopressin) launched in 13 European markets with revenues up 80%

Aloxi revenues up 84% and now recommended in key
international cancer guidelines

Acquisition of the exclusive European rights for oncology
supportive care product, Episil

Acquisition of exclusive UK rights for the oncology
supportive care product, aquoral® (Aequasyal) with
an option for Germany

Distribution and Sale Agreement for Volplex® and Isoplex® for total consideration of up to £1.4m

Download 2010 Annual report

Preliminary report FY10

Preliminary report for the period ended 30 June 2010

Download Preliminary report 2010 PDF

Interim Report 2010

Interim report for the period ended 31 December 2009

Download the Interim report 2010 PDF

IS Pharma Interim report 2010

Revenue £6.5m underlying revenues up 10% (H1 2009: £5.9m)

Gross Profit £4.5m underlying gross profit up 21% (H1 2009: £3.7m)

Cash Balance £5.1m (H1 2009: £4.2m) net cash £0.7m (2009: £0.8m)

Download 2010 Interim report

Annual Report 2009

Annual Report and Financial Statements 2009

Financial Highlights

EBITDA profit before exceptional items of £2.3m (2008:£1.3m)
Total revenue of £30.4m (2008: £30.3m)
Gross profit of £20.7m (2008: £19.4m)
Operating loss before exceptional items of £0.3m (2008: £0.8m)

Download the Annual Report 2009 PDF (PDF 1.93MB)
Download Notice of Annual General Meeting PDF (PDF 149kb)

Interim Report 2009

Interim Report for the period ended 31 December 2008

Download the Interim Report 2009 PDF (PDF 1MB)

Archived Reports

2008

Download the Annual Report 2008 PDF (PDF 1MB)
Download the Notice of Annual General Meeting 2008 PDF (PDF 135kb)
Download the Draft Articles of Association PDF (PDF 350kb)
Download the AGM Circular to shareholders PDF (PDF 159kb)

2007

Download the Interim Report 2007 PDF (PDF 284kb)
Interactive Annual Report 2007
Interim Results FY2007 - Presentation (.PDF 1.87Mb)

2006

Annual Report to 30 June 2006 (PDF, 684kb)
Interactive Annual Report 2006

2005

Interim Report to 31st December 2005 (PDF, 224kb)
Annual Report to 30 June 2005 (PDF, 684kb)

2004

Annual Report to 30 June 2004 (PDF, 485kb)

2003

Interim Report to 31st December 2003 (PDF 130kb)

Member space

Subscribe
Forgot Password

Email

Password
Latest news

01/13/2012 07:00

Trading update Trading update

12/08/2011 07:00

Acquisition of Advanced Bio-Technologies Inc. Acquisition of Advanced Bio-Technologies Inc.

11/15/2011 07:00

Disposal of Mysoline Disposal of Mysoline
Message from SPH CEO

Read more
SPH Share price

This frame displays Sinclair Pharma's share price, if you can't view this feed please access the price directly at <a href="http://qq.axl.co.uk/axl-dlls/publish?url=/templates/ir/sinclairpharma/tinyprice.html">http://qq.axl.co.uk/axl-dlls/publish?url=/templates/ir/sinclairpharma/tinyprice.html</a>
Charity

On 15^th May 2011 Sinclair Pharma’s employees united to take part in ‘Walk the Wight’, the annual fundraising event organised by and in aid of the Earl Mountbatten Hospice on the Isle of Wight.

Sinclair Pharma’s team was comprised of 42 employees from Sinclair’s affiliates in France, Italy, Spain and the UK, who had donated their weekend to participate in the walk which began in Bembridge and ended in Carisbrooke, covering a total distance of 20 km. The walking time amassed to six hours and 15 minutes, during which the team tackled the undulating paths of the island’s terrain, battling the discomfort of blisters and aching limbs. In order to enhance the challenge, the team of walkers also camped out in tents on the eve of the event, managing with tremendous spirit to both construct and dismantle the tents before and after use.

While Sinclair’s employees have long been supporters of various charitable causes, this year’s ‘Walk the Wight’ marks the first time that members from all affiliates were invited to join together to engage in a common fundraising activity – an initiative that will soon be repeated as Sinclair develops its charity programme. We are delighted to confirm that Sinclair has raised a total sum of £10,088 for the event’s organiser and charity, the Earl Mountbatten Hospice.

The weekend was a great team building experience for all involved and thanks are owed to both the participants and sponsors, whose respective contributions rendered the event a terrific success.